223 related articles for article (PubMed ID: 30777126)
1. Early progression of Krabbe disease in patients with symptom onset between 0 and 5 months.
Beltran-Quintero ML; Bascou NA; Poe MD; Wenger DA; Saavedra-Matiz CA; Nichols MJ; Escolar ML
Orphanet J Rare Dis; 2019 Feb; 14(1):46. PubMed ID: 30777126
[TBL] [Abstract][Full Text] [Related]
2. A prospective natural history study of Krabbe disease in a patient cohort with onset between 6 months and 3 years of life.
Bascou N; DeRenzo A; Poe MD; Escolar ML
Orphanet J Rare Dis; 2018 Aug; 13(1):126. PubMed ID: 30089515
[TBL] [Abstract][Full Text] [Related]
3. Consensus guidelines for newborn screening, diagnosis and treatment of infantile Krabbe disease.
Kwon JM; Matern D; Kurtzberg J; Wrabetz L; Gelb MH; Wenger DA; Ficicioglu C; Waldman AT; Burton BK; Hopkins PV; Orsini JJ
Orphanet J Rare Dis; 2018 Feb; 13(1):30. PubMed ID: 29391017
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics of 248 patients with Krabbe disease: quantitative natural history modeling based on published cases.
Komatsuzaki S; Zielonka M; Mountford WK; Kölker S; Hoffmann GF; Garbade SF; Ries M
Genet Med; 2019 Oct; 21(10):2208-2215. PubMed ID: 30899093
[TBL] [Abstract][Full Text] [Related]
5. Early infantile Krabbe disease: results of the World-Wide Krabbe Registry.
Duffner PK; Barczykowski A; Jalal K; Yan L; Kay DM; Carter RL
Pediatr Neurol; 2011 Sep; 45(3):141-8. PubMed ID: 21824559
[TBL] [Abstract][Full Text] [Related]
6. Early infantile Krabbe disease: deceptively normal magnetic resonance imaging and serial neurophysiological studies.
Zafeiriou DI; Anastasiou AL; Michelakaki EM; Augoustidou-Savvopoulou PA; Katzos GS; Kontopoulos EE
Brain Dev; 1997 Nov; 19(7):488-91. PubMed ID: 9408597
[TBL] [Abstract][Full Text] [Related]
7. Newborn screening for Krabbe disease: the New York State model.
Duffner PK; Caggana M; Orsini JJ; Wenger DA; Patterson MC; Crosley CJ; Kurtzberg J; Arnold GL; Escolar ML; Adams DJ; Andriola MR; Aron AM; Ciafaloni E; Djukic A; Erbe RW; Galvin-Parton P; Helton LE; Kolodny EH; Kosofsky BE; Kronn DF; Kwon JM; Levy PA; Miller-Horn J; Naidich TP; Pellegrino JE; Provenzale JM; Rothman SJ; Wasserstein MP
Pediatr Neurol; 2009 Apr; 40(4):245-52; discussion 253-5. PubMed ID: 19302934
[TBL] [Abstract][Full Text] [Related]
8. Early peripheral nervous system manifestations of infantile Krabbe disease.
Korn-Lubetzki I; Dor-Wollman T; Soffer D; Raas-Rothschild A; Hurvitz H; Nevo Y
Pediatr Neurol; 2003 Feb; 28(2):115-8. PubMed ID: 12699861
[TBL] [Abstract][Full Text] [Related]
9. Krabbe disease: severe neonatal presentation with a family history of multiple sclerosis.
Sahai I; Baris H; Kimonis V; Levy HL
J Child Neurol; 2005 Oct; 20(10):826-8. PubMed ID: 16417879
[TBL] [Abstract][Full Text] [Related]
10. Natural history of Krabbe disease - a nationwide study in Germany using clinical and MRI data.
Krieg SI; Krägeloh-Mann I; Groeschel S; Beck-Wödl S; Husain RA; Schöls L; Kehrer C
Orphanet J Rare Dis; 2020 Sep; 15(1):243. PubMed ID: 32912261
[TBL] [Abstract][Full Text] [Related]
11. Psychosine, a marker of Krabbe phenotype and treatment effect.
Escolar ML; Kiely BT; Shawgo E; Hong X; Gelb MH; Orsini JJ; Matern D; Poe MD
Mol Genet Metab; 2017 Jul; 121(3):271-278. PubMed ID: 28579020
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal Stem Cells Yield Transient Improvements in Motor Function in an Infant Rhesus Macaque with Severe Early-Onset Krabbe Disease.
Isakova IA; Baker KC; Dufour J; Phinney DG
Stem Cells Transl Med; 2017 Jan; 6(1):99-109. PubMed ID: 28170189
[TBL] [Abstract][Full Text] [Related]
13. A staging system for infantile Krabbe disease to predict outcome after unrelated umbilical cord blood transplantation.
Escolar ML; Poe MD; Martin HR; Kurtzberg J
Pediatrics; 2006 Sep; 118(3):e879-89. PubMed ID: 16923928
[TBL] [Abstract][Full Text] [Related]
14. Optic nerve enlargement in Krabbe disease: a pathophysiologic and clinical perspective.
Hussain SA; Zimmerman HH; Abdul-Rahman OA; Hussaini SM; Parker CC; Khan M
J Child Neurol; 2011 May; 26(5):642-4. PubMed ID: 21285037
[TBL] [Abstract][Full Text] [Related]
15. Late-onset Krabbe disease is predominant in Japan and its mutant precursor protein undergoes more effective processing than the infantile-onset form.
Hossain MA; Otomo T; Saito S; Ohno K; Sakuraba H; Hamada Y; Ozono K; Sakai N
Gene; 2014 Jan; 534(2):144-54. PubMed ID: 24252386
[TBL] [Abstract][Full Text] [Related]
16. Pathogenic Variants in
Bascou NA; Beltran-Quintero ML; Escolar ML
Front Neurol; 2020; 11():563724. PubMed ID: 33178108
[No Abstract] [Full Text] [Related]
17. Krabbe disease: clinical, biochemical and molecular information on six new patients and successful retrospective diagnosis using stored newborn screening cards.
Puckett RL; Orsini JJ; Pastores GM; Wang RY; Chang R; Saavedra-Matiz CA; Torres PA; Zeng B; Caggana M; Lorey F; Abdenur JE
Mol Genet Metab; 2012 Jan; 105(1):126-31. PubMed ID: 22115770
[TBL] [Abstract][Full Text] [Related]
18. Long-term neurodevelopmental outcomes of hematopoietic stem cell transplantation for late-infantile Krabbe disease.
Yoon IC; Bascou NA; Poe MD; Szabolcs P; Escolar ML
Blood; 2021 Apr; 137(13):1719-1730. PubMed ID: 33150395
[TBL] [Abstract][Full Text] [Related]
19. Regional differences in fiber tractography predict neurodevelopmental outcomes in neonates with infantile Krabbe disease.
Gupta A; Poe MD; Styner MA; Panigrahy A; Escolar ML
Neuroimage Clin; 2015; 7():792-8. PubMed ID: 25844309
[TBL] [Abstract][Full Text] [Related]
20. Altered Trafficking and Processing of GALC Mutants Correlates with Globoid Cell Leukodystrophy Severity.
Shin D; Feltri ML; Wrabetz L
J Neurosci; 2016 Feb; 36(6):1858-70. PubMed ID: 26865610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
